BrUOG 302:BYL719, Capecitabine and Radiation for Rectal Cancer: A Brown University Oncology Research Group Phase I Study
Phase of Trial: Phase I
Latest Information Update: 24 Dec 2016
At a glance
- Drugs Alpelisib (Primary) ; Capecitabine
- Indications Rectal cancer
- Focus Adverse reactions
- 03 Jun 2016 Status changed from not yet recruiting to recruiting.
- 04 Mar 2016 Planned initiation date changed from 1 Dec 2015 to 1 Apr 2016, according to ClinicalTrials.gov record.
- 19 Sep 2015 New trial record